World Neurosurgery
Volume 73, Issue 2 , Pages 128-134 , February 2010

Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival?

  • Faramarz- Allahdini, MD

      Affiliations

    • Sina Hospital, Tehran University of Medical Sciences, (TUMS), Tehran 19585-678, Iran
    • ,
  • Abbass Amirjamshidi, MD, MPH

      Affiliations

    • Sina Hospital, Tehran University of Medical Sciences, (TUMS), Tehran 19585-678, Iran
    • Corresponding Author InformationCorresponding author. Fax: +00982177500958.
    • ,
  • Mohammad Reza-Zarei, MD, MPH

      Affiliations

    • Trauma Centre, Sina Hospital, Tehran University of Medical Sciences, Tehran 19585-678, Iran
    • ,
  • Morteza Abdollahi, MD, PhD

      Affiliations

    • Trauma Centre, Sina Hospital, Tehran University of Medical Sciences, Tehran 19585-678, Iran

Received 2 November 2007 ,Accepted 4 June 2009.

References 

  1. Albert FK, Forsting M, Sartor K, et al. Early post-operative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neourosurgery. 1994;34:45–61
  2. Ammirati M, Galicirch JH, Arbit E, et al. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurg. 1987;21:607–614
  3. Ammirati M, Vick N, Liao Y, Ciric I, et al. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery. 1987;21:201–206
  4. Barker FG, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer. 1997;80:936–941
  5. Barker FG, Prados MD, Chang SM, Gutin PH, Lambom KR, et al. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg. 1996;84:442–448
  6. Bauman G, Pahapill P, Macdonald D, et al. Low grade glioma, a measuring radiographic response to radiotherapy. Can J Neurol Sci. 1999;26:18–22
  7. Burger PC, Heinz ER, Shibata T, Kleihues P. Topographic analysis and CT correlations in untreated glioblastoma multiforme. J Neurosurg. 1988;68:698–704
  8. Ciric I, Ammirati M, Vick NA, Mikhael MA. Supratentorial gliomas: surgical considerations and immediate postoperative imaging. Neurosurgery. 1987;21:21–26
  9. Ciric I, Vick NA, Mikhael MA, Cozzens J, et al. Aggressive surgery for malignant supratentorial gliomas. Clin Neurosurg. 1990;36:375–383
  10. Coffey RJ, Lunsford LD, Taylor FH. Survival after stereotactic biopsy of malignant gliomas. Neurosurgery. 1990;22:465–473
  11. Fadul C, Wood J, Thaler H, et al. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology. 1988;38:1374–1379
  12. Harsh GR, Keating MT, Escobedo JA, et al. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery. 1987;21:615–621
  13. Harsh GRIV, Levin VA, Gutin PH, et al. Reoperation for recurrent glioblastoma multiforme and anaplastic astrocytoma. Neurosurgery. 1987;21:615–621
  14. Hentschel SJ, Sawaya R, et al. Optimizing outcomes with maximal surgical resection of malignant gliomas. Cancer Control. 2003;10:109–114
  15. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology. 1980;30:907–911
  16. Jackson RJ, Fuller GN, Abi-Said D, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol. 2001;31:193–200
  17. Karnofsky DA, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer.. In:  Macleod CM editors. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949;p. 191–205
  18. Keles GE, Lamborn KR, Chang SM, et al. Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastoma multiforme who are undergoing chemotherapy. J Neurosurg. 2004;100:41–46
  19. Kondziolka D, Lunsford LD. The role of stereotactic biopsy in the management of gliomas. J Neurooncol. 1999;42:205–213
  20. Lacronix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection and survival. J Neurosurg. 2001;95:190–198
  21. Liang BC, Thornton AF, Sandler HM, Greenberg HS. Malignant astrocytoma: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg. 1991;75:559–563
  22. Nazzaro JM, Neuwelt EA. The role of surgery in the management of supratentorial intermediate and high grade astrocytoma in adults. J Neurosurg. 1990;73:331–344
  23. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62:753–760
  24. Santiago P, Silbergeld DL. Malignant gliomas, anaplastic astrocytomas, glioblastoma multiforme, malignant oligodendroglioma. In: Youmans Neurological surgery. 5th ed. W.B. Saunders; 2004;
  25. Sawaya R, Hammoud M, Schoppa D, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery. 1998;42:1044–1046
  26. Shafqat S, Hedley-White ET, Henson JW. Age-dependent rate of anaplastic transformations in low-grade astrocytoma. Neurology. 1999;52:867–869
  27. Stewart LA. Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet. 2002;359:1011–1018
  28. Stummer W, Reulen HJ, Meinel T, Pichlemer U, Schumacher W, Tonn JC, et al. Extent of resection and survival in glioblastoma multiformis: identification of and adjustment for bias. Neurosurgery. 2008;62:564–578
  29. Sze G. New applications of MR contrast agents in neuroradiology. Neuroradiology. 1990;32:421–438
  30. Tatter SB, Wilson GB, Horsh GR. Neuroepithelial tumors of the adult brain. In:  Youmans JR editors. Neurological surgery. 4th ed. W.B. Saunders; 1996;p. 2612–2684
  31. Taveras JM, Thompson HG, Pool JL. Should we treat glioblastoma multiforme? A study of Survival in 425 Cases. AJR Am J Roentgenol. 1962;87:473–479
  32. Walker MD, Green SB, Byor DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery. N Engl J Med. 1980;303:1323–1329
  33. Wisoff JH, Boyett JM, Berger MS, Brant C, Li H, Yates AJ, et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg. 1998;89:52–59

PII: S0090-3019(09)00854-4

doi: 10.1016/j.wneu.2009.06.001

World Neurosurgery
Volume 73, Issue 2 , Pages 128-134 , February 2010

Article Tools